Cencora, Inc. (COR)
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Latest Price
$326.23
TTM P/E
24.22
Normalized P/E
33.05
Div Yield
0.72%
Book Value
15.80
P/B Ratio
20.65
Valuation metrics
adjust assumptions →EPS: $7.96
Book value / share: $7.78
Formula: √(22.5 × EPS × BVPS)
Graham Number
$37.32
88% downside
Norm. op. income: $2.3B (median of 7yr)
Tax rate: 24%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$74.17
77% downside
Base FCF: $3.0B (median of recent 5yr)
Growth: 3%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$209.98
35% downside
EPS: $7.96
Target P/E: 33×
Formula: EPS × P/E
P/E Fair Value
$262.68
18% downside
Institutional Ownership
95.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 18.21M | $5.15B | 9.54% | -1.73M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.38M | $3.50B | 6.49% | -- | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 9.61M | $2.72B | 5.04% | -- | 2026-06-30 |
| STATE STREET CORP | 9.27M | $2.62B | 4.86% | +83.4K | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 7.41M | $2.10B | 3.88% | +1.12M | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.13M | $2.02B | 3.74% | -191.0K | 2026-06-30 |
| JPMORGAN CHASE & CO | 5.94M | $1.67B | 3.11% | +961.1K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 5.45M | $1.54B | 2.86% | -111.2K | 2026-06-30 |
| Boston Partners | 4.87M | $1.38B | 2.55% | +386.0K | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.56M | $1.29B | 2.39% | +11.1K | 2026-06-30 |